These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
525 related items for PubMed ID: 29208760
1. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study. Autier P, Boniol M, Koechlin A, Pizot C, Boniol M. BMJ; 2017 Dec 05; 359():j5224. PubMed ID: 29208760 [Abstract] [Full Text] [Related]
2. Mammography screening: A major issue in medicine. Autier P, Boniol M. Eur J Cancer; 2018 Feb 05; 90():34-62. PubMed ID: 29272783 [Abstract] [Full Text] [Related]
4. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT. Duffy S, Vulkan D, Cuckle H, Parmar D, Sheikh S, Smith R, Evans A, Blyuss O, Johns L, Ellis I, Sasieni P, Wale C, Myles J, Moss S. Health Technol Assess; 2020 Oct 05; 24(55):1-24. PubMed ID: 33141657 [Abstract] [Full Text] [Related]
5. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women. Hendrick RE. Radiology; 2018 May 05; 287(2):391-397. PubMed ID: 29267146 [Abstract] [Full Text] [Related]
7. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Kalager M, Adami HO, Bretthauer M, Tamimi RM. Ann Intern Med; 2012 Apr 03; 156(7):491-9. PubMed ID: 22473436 [Abstract] [Full Text] [Related]
8. The role of pre-invasive disease in overdiagnosis: A microsimulation study comparing mass screening for breast cancer and cervical cancer. van Luijt PA, Rozemeijer K, Naber SK, Heijnsdijk EA, van Rosmalen J, van Ballegooijen M, de Koning HJ. J Med Screen; 2016 Dec 03; 23(4):210-216. PubMed ID: 27068430 [Abstract] [Full Text] [Related]
9. Long-term relationships between screening rates, breast cancer characteristics, and overdiagnosis in US counties, 1975-2009. Harding C, Pompei F, Burmistrov D, Wilson R. Int J Cancer; 2019 Feb 01; 144(3):476-488. PubMed ID: 30264887 [Abstract] [Full Text] [Related]
10. Overdiagnosis by mammographic screening for breast cancer studied in birth cohorts in The Netherlands. Ripping TM, Verbeek AL, Fracheboud J, de Koning HJ, van Ravesteyn NT, Broeders MJ. Int J Cancer; 2015 Aug 15; 137(4):921-9. PubMed ID: 25612892 [Abstract] [Full Text] [Related]
12. Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis. Jørgensen KJ, Gøtzsche PC, Kalager M, Zahl PH. Ann Intern Med; 2017 Mar 07; 166(5):313-323. PubMed ID: 28114661 [Abstract] [Full Text] [Related]
13. Benefit-to-harm ratio of the Danish breast cancer screening programme. Beau AB, Lynge E, Njor SH, Vejborg I, Lophaven SN. Int J Cancer; 2017 Aug 01; 141(3):512-518. PubMed ID: 28470685 [Abstract] [Full Text] [Related]
14. [Tailored Breast Screening Trial (TBST)]. Paci E, Mantellini P, Giorgi Rossi P, Falini P, Puliti D, TBST Working Group. Epidemiol Prev; 2013 Aug 01; 37(4-5):317-27. PubMed ID: 24293498 [Abstract] [Full Text] [Related]
17. [Overdiagnosis in mammography screening]. Zahl PH, Maehlen J. Tidsskr Nor Laegeforen; 2004 Sep 09; 124(17):2238-9. PubMed ID: 15356688 [Abstract] [Full Text] [Related]
18. Extrapolation of pre-screening trends: Impact of assumptions on overdiagnosis estimates by mammographic screening. Ripping TM, Verbeek AL, Ten Haaf K, van Ravesteyn NT, Broeders MJ. Cancer Epidemiol; 2016 Jun 09; 42():147-53. PubMed ID: 27153471 [Abstract] [Full Text] [Related]
19. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group. Lynge E. APMIS Suppl; 1998 Jun 09; 83():1-44. PubMed ID: 9850674 [Abstract] [Full Text] [Related]